Cargando…

How to approach genome wars in sepsis?

Sepsis continues to pose a clear challenge as one of the most difficult and costly problems to treat and prevent. Sepsis is caused by systemic or localized infections that damage the integrity of microcirculation in multiple organs. The challenge of sepsis and its long-term sequelae was addressed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawiger, Jack, Musser, James M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388672/
https://www.ncbi.nlm.nih.gov/pubmed/22136332
http://dx.doi.org/10.1186/cc10482
_version_ 1782237223753613312
author Hawiger, Jack
Musser, James M
author_facet Hawiger, Jack
Musser, James M
author_sort Hawiger, Jack
collection PubMed
description Sepsis continues to pose a clear challenge as one of the most difficult and costly problems to treat and prevent. Sepsis is caused by systemic or localized infections that damage the integrity of microcirculation in multiple organs. The challenge of sepsis and its long-term sequelae was addressed by the National Institutes of Health National Heart Lung and Blood Institute Division of Blood Diseases and Resources. Defining sepsis as severe endothelial dysfunction syndrome that causes multiorgan failure in response to intravascular or extravascular microbial agents, the National Heart Lung and Blood Institute panel proposed the concept of genome wars as a platform for new diagnostic, therapeutic, and preventive approaches to sepsis.
format Online
Article
Text
id pubmed-3388672
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33886722012-12-02 How to approach genome wars in sepsis? Hawiger, Jack Musser, James M Crit Care Commentary Sepsis continues to pose a clear challenge as one of the most difficult and costly problems to treat and prevent. Sepsis is caused by systemic or localized infections that damage the integrity of microcirculation in multiple organs. The challenge of sepsis and its long-term sequelae was addressed by the National Institutes of Health National Heart Lung and Blood Institute Division of Blood Diseases and Resources. Defining sepsis as severe endothelial dysfunction syndrome that causes multiorgan failure in response to intravascular or extravascular microbial agents, the National Heart Lung and Blood Institute panel proposed the concept of genome wars as a platform for new diagnostic, therapeutic, and preventive approaches to sepsis. BioMed Central 2011 2011-12-02 /pmc/articles/PMC3388672/ /pubmed/22136332 http://dx.doi.org/10.1186/cc10482 Text en Copyright ©2011 BioMed Central Ltd
spellingShingle Commentary
Hawiger, Jack
Musser, James M
How to approach genome wars in sepsis?
title How to approach genome wars in sepsis?
title_full How to approach genome wars in sepsis?
title_fullStr How to approach genome wars in sepsis?
title_full_unstemmed How to approach genome wars in sepsis?
title_short How to approach genome wars in sepsis?
title_sort how to approach genome wars in sepsis?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388672/
https://www.ncbi.nlm.nih.gov/pubmed/22136332
http://dx.doi.org/10.1186/cc10482
work_keys_str_mv AT hawigerjack howtoapproachgenomewarsinsepsis
AT musserjamesm howtoapproachgenomewarsinsepsis